Clinical Trial Update: Comparing One Intraarticular Injection of a Novel HYAJOINT Plus With Synvisc-One for the Treatment of Knee OA [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing a novel intraarticular injection (HYAJOINT Plus) with Synvisc-One for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• HYAJOINT Plus (hyaluronic acid-based intraarticular injection)
• Synvisc-One (hylan G-F 20)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Knee Osteoarthritis | Phase 2, Phase 3 | Status: COMPLETED